Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02181647 · ClinicalTrials.gov registry record · NA

Safe Touches: A Rigorous Evaluation of a Sexual Abuse Prevention Program for Children

A NA study of Child Sexual Abuse, sponsored by The New York Society for the Prevention of Cruelty to Children.

Completed
Registry status
NA
Development phase
492
Enrollment target
1
Study location

NCT02181647: Completed NA study of Child Sexual Abuse, sponsored by The New York Society for the Prevention of Cruelty to Children.

NCT02181647 is a NA study of Child Sexual Abuse that has completed, run by The New York Society for the Prevention of Cruelty to Children. The registered enrollment target is 492 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02181647, a NA study of Child Sexual Abuse, has completed, sponsored by The New York Society for the Prevention of Cruelty to Children.

COMPLETED
Registry status
NA
Development phase
492 participants
Enrollment target
1
Study location

Study Summary

The primary goal of the study is to conduct a rigorous evaluation of the sexual abuse prevention program entitled, "Safe Touches: Personal Safety Training for Children (Safe Touches)." The main study hypothesis is that children who receive the Safe Touches intervention will show greater improvement on their knowledge of inappropriate touches compared to children who do not receive the intervention.

Conditions Studied

Interventions

  • BEHAVIORAL Safe Touches: Personal Safety Training for Children

Study Locations (1)

New York

  • New York Society for the Prevention of Cruelty to Children - New York

Trial Details

FieldValue
Enrollment Target 492 participants
Start Date 2012-04
Est. Completion 2014-06
Phase NA

What the finished NCT02181647 record still lists

NCT02181647 is an interventional study that assigns participants to a tested intervention. The registered 492 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).

The record links to 1 condition, with Child Sexual Abuse appearing as the primary indexed condition, and to 1 intervention - of which Safe Touches: Personal Safety Training for Children is the first listed.

NCT02181647 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02181647 about?

NCT02181647 is a clinical study titled "Safe Touches: A Rigorous Evaluation of a Sexual Abuse Prevention Program for Children". The primary goal of the study is to conduct a rigorous evaluation of the sexual abuse prevention program entitled, "Safe Touches: Personal Safety Training for Children (Safe Touches)." The main study hypothesis is that children who receive the Safe Touches intervention will show greater improvement ...

What is the current status of trial NCT02181647?

This trial is currently completed. It is a NA study. The enrollment target is 492 participants. The study started on 2012-04. Estimated completion is 2014-06.

What conditions does trial NCT02181647 study?

This clinical trial studies the following conditions: Child Sexual Abuse.

What interventions are being tested in trial NCT02181647?

The interventions under investigation include: Safe Touches: Personal Safety Training for Children (BEHAVIORAL).

Who is sponsoring clinical trial NCT02181647?

This trial is sponsored by The New York Society for the Prevention of Cruelty to Children, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02181647 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Child Sexual Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02181647's enrollment target sits among peer trials

492 213th of 2000 higher than 1,786 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05861973 · 492 participants · NA

    SMARTer Weight Loss Management

  • NCT05908331 · 492 participants · NA

    MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

  • NCT06152575 · 492 participants · Phase 3

    MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  • NCT06953089 · 492 participants · Phase 2

    DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02181647, the US trial registry maintained by the National Library of Medicine. NCT02181647 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.